NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Innovative Industrial Properties, Inc. (NYSE:IIPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/innovative-industrial-properties-inc-lawsuit-submission-form?prid=128605&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Crocs, Inc. (NASDAQ: CROX) between November 3, 2022 and October 28, 2024, inclusive (the "Class Period"), of the important March 24, 2025 lead plaintiff deadline. So what: If you purchased Crocs common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WisdomTree's U.S. LargeCap ETF has high ratings from Morningstar and Lipper Leaders, but its returns are mediocre compared to the S&P 500. The WisdomTree Large Cap Index, which EPS tracks, includes 500 large U.S. companies but underperforms in profit generation and risk control. Despite its quantitative weighting method, EPS shows no significant advantage over the overall market, with a notable tracking error of 23 basis points annually.

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ: AZN) between February 23, 2022 and December 17, 2024, both dates inclusive (the "Class Period"), of the February 21, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If you purchased AstraZeneca securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Affirm reported strong Q2 results, with 47% YoY revenue growth and a GAAP EPS of $0.23, significantly above expectations, demonstrating profitability and market leadership. Despite a premium valuation, Affirm's exceptional execution, market-leading growth, and profitability support a bullish outlook, though valuation concerns temper enthusiasm slightly. Key risks include intense competition, potential credit quality downturns, and the high premium valuation.

Evaluating iShares U.S. Utilities ETF as an investment option, focusing on U.S. utilities like electricity, gas, water, and waste management services. Other cyclical sectors, such as Technology, Consumer Discretionary, and Industrials are more expensive, making Utilities a potential value play. Climate and political risks are present, but I believe the potential value here outweighs those risks. I am shifting my rating on IDU to "buy."

Gold (XAUUSD) price surged to a fresh record past $2,900 Monday as President Trump announced 25% tariffs on steel and aluminum imports and investors brace for inflation data later this week.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pliant Therapeutics, Inc. ("Pliant Therapeutics, Inc.") (NASDAQ:PLRX) concerning possible violations of federal securities laws. On February 7, 2025, Pliant announced that following a prespecified data review and recommendations by the trial's independent Data Safety Monitoring Board, it had voluntarily paused enrollment and dosing in the ongoing BEACON-IPF Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Skyworks Solutions, Inc. ("Skyworks Solutions, Inc.") (NASDAQ:SWKS) concerning possible violations of federal securities laws. Skyworks issued a press release on February 5, 2025, reporting its financial results for its fiscal quarter ended December 27, 2024.

NEW ORLEANS, LA / ACCESS Newswire / February 10, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 21, 2025 to file lead plaintiff applications in a securities class action lawsuit against Capri Holdings Limited (the "Company") (NYSE:CPRI), if they purchased the Company's shares and/or sold Capri puts between August 10, 2023 and October 24, 2024, inclusive (the "Class Period").

SALT LAKE CITY , Feb. 10, 2025 /PRNewswire/ -- Sera Prognostics, Inc., The Pregnancy Company® ("Sera" or the "Company") (Nasdaq: SERA), which focuses on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the pricing of its underwritten public offering of 1,250,000 shares of its Class A common stock at a public offering price of $4.00 per share, and, in lieu of Class A common stock to certain investors, pre-funded warrants to purchase 11,250,000 shares of its Class A common stock at a public offering price of $3.9999 per pre-funded warrant, which …

Centrus Energy reported a strong Q4 earnings beat, driving a 30% stock surge. The company benefits from the growing nuclear energy sector, with unique HALEU production capabilities positioning it for long-term growth. Centrus Energy has a $3.7 billion backlog, providing a strong revenue pipeline and safety net for investors.

NEW ORLEANS, LA / ACCESS Newswire / February 10, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March 14, 2025 to file lead plaintiff applications in a securities class action lawsuit against Pacira BioSciences, Inc. (the "Company") (NasdaqGS:PCRX), if they purchased the Company's securities between August 2, 2023 and August 8, 2024, inclusive (the "Class Period").

NEW ORLEANS, LA / ACCESS Newswire / February 10, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March 18, 2025 to file lead plaintiff applications in a securities class action lawsuit against FTAI Aviation Ltd.

NEW ORLEANS, LA / ACCESS Newswire / February 10, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 25, 2025 to file lead plaintiff applications in a securities class action lawsuit against Nextracker Inc. (the "Company") (NasdaqGS:NXT), if they purchased the Company's shares between February 1, 2024 and August 1, 2024, inclusive (the "Class Period").

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Integral Ad Science Holding Corp. (NASDAQ:IAS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/integral-ad-science-lawsuit-submission-form?prid=128598&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your MGP Ingredients, Inc. (NASDAQ:MGPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/mgp-ingredients-inc-lawsuit-submission-form?prid=128592&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=128593&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Grocery Outlet Holding Corp. (NASDAQ:GO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/grocery-outlet-holding-corp-lawsuit-submission-form?prid=128599&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=128594&wire=1 or contact Joseph E. Levi, Esq.